Metformin is widely used to manage type 2 diabetes, but recent research suggests it may have another surprising benefit—it could help the body fight cancer. Scientists at the University of Helsinki ...
The Indian phenotype of T2DM patients is associated with clustering of cardiovascular risk factors, increased insulin ...
Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.
Daily metformin with or without a Mediterranean ... 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled trial, according to findings published ...
Nicotinamide riboside was provided by Evandro Fei Fang (University of Oslo, Norway). The cells were seeded in six-well plates and treated with metformin (Sigma-Aldrich, St. Louis, MO, United States) ...
The study also emphasizes that no single drug can work for everyone. For metformin and other treatments, doctors must carefully evaluate each patient’s situation to decide whether the benefits ...
Xarelto is a brand name of the drug rivaroxaban. Medicare covers the cost of prescription medications, including Xarelto, under certain conditions. A person must be enrolled in a Medicare Part D ...
Two separate groups of medical experts and political advisers in Shanghai and Beijing are sounding the alarm over the country’s centralized drug procurement system and the drugs on a list of ...
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality. By Alexandra Stevenson and Zixu Wang Reporting from Hong Kong A rare ...
For example, should such glucose lowering drugs be discontinued at the point of remission, and can specific drug mechanisms be ... now co-first line drugs (with metformin) for many patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback